Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 198

Results For "SPI"

2504 News Found

Mankind Pharma acquires two brands from Dr Reddy’s
News | February 16, 2022

Mankind Pharma acquires two brands from Dr Reddy’s

The entire integration and transition of the brands is expected to be completed by March 2022


Lynparza plus abiraterone effective in standard-of-care in 1st-line metastatic castration-resistant prostate cancer
Biotech | February 15, 2022

Lynparza plus abiraterone effective in standard-of-care in 1st-line metastatic castration-resistant prostate cancer

These results will be presented on 17 February at the 2022 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium


UFlex introduces a range of innovative and sustainable packaging solutions
Packaging | February 15, 2022

UFlex introduces a range of innovative and sustainable packaging solutions

Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021


India’s tech-enabled vaccination drive applauded at India-Africa Health Summit
Healthcare | February 15, 2022

India’s tech-enabled vaccination drive applauded at India-Africa Health Summit

It will open new frontier for south-to-south collaboration and innovation transfer


Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19
Drug Approval | February 14, 2022

Lilly's bebtelovimab receives EUA to treat mild-to-moderate Covid-19

Bebtelovimab neutralizes Omicron as demonstrated by pseudo virus and authentic virus data


WHO prequalifies first monoclonal antibody - tocilizumab – to treat Covid-19
Drug Approval | February 14, 2022

WHO prequalifies first monoclonal antibody - tocilizumab – to treat Covid-19

The three prequalified products are manufactured by the originator company, Roche, but the listings should pave the way for more companies coming forward to seek WHO prequalification


Glenmark to commercialize AstraZeneca’s asthma drug in Columbia
Biotech | February 14, 2022

Glenmark to commercialize AstraZeneca’s asthma drug in Columbia

AstraZeneca will hold the registration and manufacture Pulmicort Respules, while Glenmark will commercialize the product in Columbia


Divi’s Labs Q3 driven by custom synthesis; margins sustainable: ICICI Direct
News | February 14, 2022

Divi’s Labs Q3 driven by custom synthesis; margins sustainable: ICICI Direct

Key takeaways of recent quarter & conference call highlights


Gamida Cell initiates rolling submission of Biologics License Application for Omidubicel
Biotech | February 10, 2022

Gamida Cell initiates rolling submission of Biologics License Application for Omidubicel

On track to complete the BLA submission in the first half of 2022


Health Canada gives breakthrough approval for Dolphin Vagal Stim device to treat Covid-19
Drug Approval | February 10, 2022

Health Canada gives breakthrough approval for Dolphin Vagal Stim device to treat Covid-19

The vagus nerve is the longest nerve in the body that travels down from the brain to innervate and control breathing, stress levels and inflammation